In the February issue of Gynecologic Oncology, SGO Payment Reform Subcommittee members Jhalak Dholakia, MD, Margaret I. Liang, MD, and Emeline M. Aviki, MD, MBA, published the article, “Missing the target: The oncology care model treatment pricing scheme is prohibitively reductive for gynecologic malignancies.”
The article goes over alternative payment models that incentivize value-based cancer care, and posits that APMs that incorporate treatment pathways in target price calculations may more closely represent real-world practice.